A two step tumor test for children and young adults with tumors that came back
Original title: Pedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expression in Relapsed/Refractory Pediatric Solid and CNS Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study lists no phase, and it is still being tried out in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study checks if a tumor test can find proteins that certain drugs aim at.
Who this trial is for. This trial is for children and young adults with solid tumors or tumors of the brain and spinal cord. Their tumors came back or did not respond to treatment. It tests a two step way of looking at tumor samples for the proteins that antibody drug conjugates aim at.
Where it stands. The trial has not reported results. It is measuring whether this way of testing tumors can be done. The first step reads the tumor's genes to see which of these targets are turned on. The second step checks those tumors again to confirm the protein is really there. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If your child has a solid tumor or a brain or spinal cord tumor that came back, this is a test of a tumor testing method. It does not give a new treatment. If it seems to fit, you can ask your care team about it.
What it doesn't mean: This does not mean the testing method works. A trial is a test, not proven care. Joining a trial is not a promise that it will help. It is not a cure, and it is not a promise of one. The trial team decides who can take part.
Source: ClinicalTrials.gov, August 31, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.